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Placental malaria is recognized as a common complication of malaria in pregnancy in areas
of stable transmission, and, as a consequence, serious health problems arise for the mother
and especially her baby [1].Although malaria in pregnancy is a major factor associated with
adverse perinatal outcome, the link between malaria and perinatal morbidity/mortality is less
clear in areas with stable endemic malaria where pregnant women have acquired immunity
[2]. Histological examination of the placenta is a predictor of fetal morbidity, as well as being
the most sensitive detector of maternal infection [3].
Adverse perinatal outcome has been described as an important indicator of poor quality of
obstetric care and social development [4]. A variety of adverse perinatal outcomes associ-
ated with placental malaria have been described, including low birth weight, preterm delivery,
intrauterine growth retardation, fetal anemia, congenital malaria, and fetal mortality. The
most common clinical features in 80 percent of perinatal cases are fever, anemia, and
splenomegaly [5]. Other signs and symptoms include hepatomegaly, jaundice, regurgitation,
loose stools, poor feeding, and, occasionally, drowsiness, restlessness, and cyanosis also
can be seen [5,6].
A review of studies that investigated these poor fetal outcomes associated with placental





fetal exposure to malaria if parasites are
transmittedacrosstheplacentaandcouldre-
sult in congenital malaria. Transplacental
transmission of P. falciparum has been well
described,andthereportedfrequencyofthis
event in babies born in malaria-exposed
pregnancies has ranged from 0 percent to
morethan25percent[7-11].Thus,placental
malaria is known to be a major determinant
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thought to be a rarity in sub-Saharan Africa,
a recent review has indicated that congenital
malaria is more common than previously
thought[12].Whilestilldebatable,congenital
malaria may be defined as the presence of
asexual stages of P. falciparum in cord blood
smearatdeliveryorinperipheralbloodsmear
of the infant in the first seven days of life, ir-
respective of clinical symptoms [12]. Nor-
mally, symptoms occur 10 to 30 days
postpartum; however, the disease may be
seeninaday-oldinfantorappearafterweeks
to months [6]. Interestingly, earlier reports
from sub-Saharan Africa rarely identified
clinical disease as a consequence of congen-
itallyacquiredmalaria,andonlyafewreports
beforethe1970sdocumenteddetectablepar-
asitemia in infants younger than one month
[7,13]. These studies were interpreted as
showing either that transplacental transmis-
sion of malaria occurs infrequently or that
after transplacental transmission some ele-
mentsofimmunityacquiredfromthemother
protects infants [8]. It has been demonstrated
that in hyperendemic areas, newborns more
rarelybecomeillwithmalariabecauseofpas-
sive maternal antibody and high levels of
fetal hemoglobin [14,15].
Postulated mechanisms for congenital
transmission include maternal transfusion
into the fetal circulation either at the time of
delivery or during pregnancy, direct penetra-
tionthroughthechorionicvilli,orpenetration
through premature separation of the placenta
[16]. However, the effectiveness of the pla-
centa to restrain malaria parasite passage to
the fetus and the remarkable capacity of the
fetus to resist infection has been demon-
strated [17]. This resistance may reflect,
amongotherthings,thephysicalbarrierofthe
placenta to infected red cells, the passive
transfer of maternal antibodies, and the poor
environment afforded by fetal erythrocytes
for plasmodial replication due to their fetal
hemoglobin composition and low free-oxy-
gen tension [16-18]. It has been implied that
transplacental transmission of malaria para-
site and, consequently, congenital malaria
seemed to occur rarely. However, increasing
reports from many parts of sub-Saharan
Africa consistently have indicated high
prevalence of umbilical cord parasitemia
rangingfrom1.5percentto54.2percent,and
in some of these studies, there was a strong
association between placental malaria and
umbilical cord parasitemia [12].
Untilrecently,itwasunclearwhetherthe
presenceofP.falciparummalariaparasitesin
umbilical cord blood is an indication of ante-
natally acquired infection or contamination
with infected maternal blood at delivery. In a
study in Kenya, it was unequivocally shown
thatmalariaparasitesidentifiedincordblood
are acquired antenatally by transplacental
transmission of infected erythrocytes and
primigravid and secundigravid women with
placentalmalariaareatincreasedriskforcon-
genital infection [19]. The high rate of
transplacental transmission of malaria ap-
pears to suggest the placental barrier is not
very effective when infected with malaria
parasites [8].
Perinatal mortality
Placental malaria and its effects on peri-
natal mortality (fetal or infant deaths from
28th week of pregnancy up to the seventh
day after birth) have been investigated in
various parts of sub-SaharanAfrica.The im-
pact of placental malaria on perinatal death
(stillbirth and early neonatal death) is still
under debate, and conflicting results have
been obtained from various studies that in-
vestigated the relationship between them.
Newman et al. reported a seven-fold in-
creased risk of stillbirth in association with
placental parasitemia in areas with unstable
malaria transmission in Ethiopia [20]. Mc-
Gregor et al. [21] observed some seasonal
differences in stillbirth rates, with the lowest
rate occurring during the three months of the
late dry season when placental malaria
prevalence was low. Conversely, in a more
recent study, Okoko et al. [22], inThe Gam-
bia, observed a two-fold increased risk of
stillbirth among mothers with malaria-in-
fected placenta and noted that placental
malaria infection was independently associ-
ated with a higher risk of delivering still-
births in the population studied. The same
conclusion was reached based on a meta-
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sub-Saharan Africa [23]. However, in some
studies in individual countries [21,24], this
association was not always found to be sta-
tistically significant. Interestingly, placental
malaria infection has been identified as pos-
sibly protective against perinatal mortality
among low birth weight (LBW†) infants
[25].The explanations for this, however, re-
main a mystery and therefore require further
exploration.
Low birth weight
In sub-SaharanAfrica, the rate of LBW
(i.e., < 2.5kg) newborns ranges from 3.9 per-
cent to 24 percent [22,26-29], and malaria is
thought to be an important contributor to the
3.5 million LBW babies born annually in
sub-SaharanAfrica [30]. Malaria is thought
to reduce birth weight through a combina-
tion of systemic and local effects [26]. Al-
though malaria may affect birth weight
through malaria-induced anemia, it also may
reduce birth weight via the effects of placen-
tal infection [22,31,32]. In this case, para-
sites either directly cause a mechanical
compromise of placental circulation via
widespread trophoblast basement thickening
and increased fibrinoid necrosis and cytro-
phoblast prominence or indirectly interfere
with placental functions and/or induce
pathological lesions [33,34]. Despite the
prevalence of placental infections for
women of all gravidities, ranging from 5
percent to 52 percent, infection-associated
LBW risk is elevated two to four times in
various studies [28,29,35]. A contradictory
study inThe Gambia showed increased birth
weight in infected placentas, but widespread
trophoblast basement membrane thickening
was associated with decreased birth weight.
Anon-significant correlation was found be-
tween LBWand increased fibrinoid necrosis
and cytotrophoblast prominence [36]. Simi-
larly, in Ubangi district, Zaire, malarious
placentas had no consistent relationship to
birth weight, and although infants born to in-
fected mothers with malarious placentas av-
eraged 100 g less, there was, however, no
significant difference in the trend [24].
There is still no agreement as to the main
mechanisms mediating reductions in birth
weight in placental malaria [26].When birth
weight is stratified and related to the types of
placental infections (chronic or active) in
different studies, there were conflicting find-
ings [22].
Since LBW is the single greatest risk
factor for neonatal and infant mortality, its
prevention through effective control of pla-
cental malaria cannot be overstated [37]. In
some studies in sub-Saharan Africa, infant
mortality is three times higher for LBW ba-
bies than for those of normal weight; effects
onneonatalmortality areevenmoremarked,
with a LBW baby being nine times more
likelytodieinthefirstmonthoflife[38-39].
Preterm delivery and intrauterine
growth retardation
The relationship between placental
malaria and preterm delivery (PTD)/in-
trauterine growth retardation (IUGR) has
been evaluated in various studies. Two ear-
lier studies among semi-immune women
failed to show a difference in the proportion
of PTD among infected and non-infected
mothers, but other reports across sub-Saha-
ranAfrica have shown that placental malaria
was significantly associated with PTD and
IUGR [40-43]. This is in contrast with re-
portsfromYaound￩,Cameroon,Malawi,and
The Gambia, where, after adjusting for po-
tentially confounding variables, the associa-
tion of placental malaria with PTD was not
found to be significant [21,44,45].
Although the precise effect of malaria-
parasitized placentas on PTD is uncertain,
malaria-infected placentas frequently carry
antibodies, cytokines, and macrophages,
which are indicative of an active immune re-
sponse,and this immune response may stim-
ulate early labor [35,46]. The biological
processes that mediate IUGR as a result of
placental malaria remain uncertain, given
that they can be studied only after the pla-
centa has been delivered. However, the
IUGR effect appears to relate to nutrient
transport to the fetus [35].Ahigh density of
parasitesandchronicparasiteinfectioninthe
placental blood and the associated cellular
immuneresponsemayresultinconsumption
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to the fetus. Histopathological studies of in-
fectedplacentashavefoundthickeningofthe
cytotrophoblasticmembranes,whichmayin-
terfere with nutrient transport [35,46].
Although IUGR is more common than
PTD with chronic placental infection,
chronic infection of the placenta (with pig-
ment and parasites) may be associated with
LBW, through both prematurity and IUGR
[26,47].Active placental infections were as-
sociated with a statistically significant lower
risk of LBW as a result of IUGR and with a
non-significant increase in the risk of LBW
as a result of prematurity [26]. This finding
suggests that acute infections toward the end
of pregnancy may play an important role in
the induction of PTD, consistent with higher
rates of abortions and preterm deliveries that
havebeenobservedduringmalariatransmis-
sionseasons[48].Becauseprematureinfants
are more likely to die than IUGR babies, the
prevention of placental malaria particularly
toward the end of gestation in malarious
areas becomes absolutely imperative [49].
Effects on Neonatal Anthropometric
Parameters
Neonatal anthropometric parameters
such as neonatal length, head circumference,
and placental weight have been related to
placental malaria. In southeastern Tanzania,
chronic ongoing malaria infection of the pla-
centa was associated with significant reduc-
tions in mean head circumference, neonatal
length, and body index (weight/length),
whereas past infections were associated only
with reduced mean length at birth [26]. In
southeastern Nigeria, a slightly higher pro-
portion of infected placenta was not signifi-
cantly associated with lower neonatal length
and lower head circumference; in the
Ubangi district of Zaire, malarious placentas
had no consistent relationship with neonatal
length or head circumference (Uneke et al.,
unpublished data) [24]. Reduction in new-
born length and head circumference associ-
ated with chronic infections probably
indicates a prolonged effect on fetal nutri-
tion, which previously has been suggested
[49,50]. Similarly, it has been suggested that
the reduction in the body mass index may
reflect the severity and duration of fetal mal-
nutrition [26].
Two earlier studies evaluated the rela-
tionship between placental malaria and pla-
cental weight in Gabon.The mean weight of
term placentas with malarial changes was
significantly less than that of placentas with-
out such changes [51,52]. In southeastern
Nigeria, placental malaria was significantly
associated with lower placental weight
(Uneke et al., unpublished data).The reason
for this reduction is not fully known, but it
may be associated with changes in the pla-
centa, including the presence of parasitized
erythrocytes and malarial pigment particles
in the intervillous space, chronic basal villi-
tis, malarial pigment deposits in the tro-
phoblasts, trophoblastic damage with focal
necrosis, partial loss of microvilli, and thick-
ening of the trophoblastic basement mem-
brane [53]. As a result of these changes, a
high density of parasites and chronic para-
site infection in the placental blood and the
associated cellular immune response may
result in consumption of glucose and oxygen
that would have gone to the fetus [35]. Pla-
cental insufficiency also could be attributa-
ble to physical blockage by parasitized red
blood cells and the massive monocyte infil-
tration of the intervillous spaces. Such infil-
trate is likely to be a source of cytokines,
including interferon-g, interleukin-2, inter-
leukin-6, and tumor necrosis factor–a, which
are considered detrimental to pregnancy be-
cause they are associated with growth retar-
dation [54].
Fetal anemia
The prevalence of fetal anemia, defined
as cord hemoglobin level < 12.5g/dl, is re-
portedly very high in sub-SaharanAfrica. In
two separate studies conducted in southern
Malawi, fetal anemia prevalences of 23.4
percent [55] and 23.3 percent [56] were
recorded, while in Maputo Mozambique, up
to 93 percent of newborns were found to
have fetal anemia [57]. Interestingly, a sta-
tistically significant link was established be-
tween fetal anemia and maternal malaria
infection in all of these studies.The contrib-
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mia has been evaluated in a number of stud-
ies with varying results.
In southern Malawi, a higher preva-
lence of fetal anemia occurred with increas-
ing peripheral P. falciparum parasite density,
and geometric mean placental parasite den-
sities were higher in babies with fetal ane-
mia than in those without it [55]. Other
studies have found no statistically signifi-
cant connection between evidence of
malaria infection and fetal anemia [58].
This lack of consistency in the findings
from various studies may be explained by
the fact that malaria in pregnancy varies
with transmission intensity, access to treat-
ment, coverage and quality of antenatal
services, and drug resistance, among other
factors [56,59,60].The etiology of fetal ane-
mia is complex and multifactorial; placental
malaria could play either a major or minor
role, depending on the local epidemiological
situation [61]. It has been suggested that ex-
posure of the fetus to malaria antigens due to
damage of the placental barrier may make
the newborn more susceptible to immuno-





Approximately 1 million pregnancies
per year are thought to be complicated by
co-infection with malaria and HIV in sub-
SaharanAfrica, because the two diseases are
known to critically intersect in pregnancy
[62,63]. HIV infection has been associated
with an increased prevalence and density of
malaria in pregnancy in a number of studies
in sub-Saharan Africa [62,64-66]. In most
studies, the prevalence of placental malaria
infection was significantly more prevalent
in HIV-positive compared with HIV-nega-
tive mothers [66-70]. In one study in
Malawi, however, HIV infection was not
significantly related to the likelihood of
malaria as detected by placental histology
[71]. Nevertheless, the increased suscepti-
bility to both peripheral malaria and placen-
tal malaria by HIVinfected pregnant women
is likely due to immunodeficiency, as it has
been shown that HIV may impair the im-
mune response to malaria in pregnancy [65].
Although in vitro experiments showed
that higher placental virus load was seen
when malaria antigen was present [72,73],
it was suggested it might be that this local
increase in virus concentration is not re-
flected in the systemic maternal virus load
[69]. Furthermore, in Malawi, a similar two-
fold increase in placental HIV-1 RNA con-
centrations was found, with the greatest
increase in women with the highest placental
parasite densities [74]. It was noted that
these observations were independent of the
degree of immunosuppression as assessed
by CD4 cell counts and thus cannot be ex-
plained by an increased risk of malaria in
subjects with more advanced immunosup-
pression and potentially greater HIV-1 viral
load [74].
Whether dual infection with placental
malaria and HIV increases the risk of
mother-to-child transmission of HIV
(MTCT) is yet to be unequivocally estab-
lished, as studies examining these relation-
ships have inconsistent findings and a wide
range of unanswered questions. Reported
prevalence of MTCT ranges from 19.4 per-
cent to 19.9 percent [64,68-69]. In some
studies, no correlation was found between
placental malaria and perinatal HIV trans-
mission; in others, a higher prevalence of
MTCT was observed among HIV-positive
mothers with placental malaria, although
other factors were not controlled for [68-69].
One report notes a lower prevalence of
MTCT among HIV-positive mothers with
placental malaria, and indicates that placen-
tal malaria, especially at lower density par-
asitemia (< 10,000 parasites/ﾵL), is
significantly associated with reduced risk for
perinatal MTCT [64].
Theseconflictingresultsontherelation-
ship between placental malaria and the risk
of MTCT, ranging from an increased risk to
noeffecttoasignificantprotectiveeffectsug-
gests there exists a complex interaction be-
tween placental malaria and HIV infection.
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parasites is associated with a higher HIV-1
load [75], and placental HIV-1 viral load is
increased in women with placental malaria,
especially those with high parasite densities
[74]. It can be hypothesized that increased
placental HIV-1 load, due to the presence of
malaria parasites, might be associated with
increased excretion of HIV-1 in the genital
tract, thus increasing the risk of MTCT. Ma-
ternal immune responses to malaria on the
onehandmaystimulateHIVviralreplication
in the placenta, thereby increasing the local
viralload.Alternatively,maternalimmunere-
sponses may control the severity of malarial
infection and HIVreplication and may either
haveaprotectiveeffectorincreasetheriskof
MTCT[62,76].Ithasbeensuggestedthatthe
direction of the effect may depend on the de-
greeofHIV-relatedimmunosuppressionand,
thus, the degree of placental monocyte infil-
trates and proinflammatory cytokine and
chemokineresponses[62]andontheseverity
of the malaria. More studies are urgently
needed to evaluate the immunological bases
for the increased susceptibility of HIV-in-
fectedmotherstobothperipheralandplacen-
tal malaria and for the effect of co-infection
on mother-to-child transmission of HIV.
CONCLUSIONS
In sub-Saharan Africa, with high birth
rates, a high endemicity of malaria, and
alarming rates of new cases of HIV, prophy-
laxis against both diseases with combination
agents during pregnancy has been described
as a great challenge [77]. Low adherence,
poor-quality drugs, and drug resistance de-
crease the effectiveness of both antiretrovi-
ral and anti-malarial drugs and may further
hamper treatment outcome and overall im-
provement of maternal and infant health.
This calls for more research on malaria and
HIV infection treatment and prevention in-
tervention strategies because only with suf-
ficient evidence can appropriate public
health policy be devised on integrating the
prevention, care, treatment, and support ac-
tivities for malaria and HIVamong pregnant
women in the sub-region.
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